Welcome to the European Association for Cancer Research
Connecting cancer researchers together
EACR-OECI Joint Virtual Conference: Molecular Pathology Approach to Cancer
Virtual event, Worldwide : 23 - 24 March 2021
Nonacus
At Nonacus we pioneer development of innovative genetic testing products which advance precision medicine and improve patient outcomes. Nonacus’ expertise in ctDNA assay development allows us to manufacture rapid custom solutions for our customers to interrogate patient mutations in their liquid biopsy samples. In addition, our same Cell3 Target technology allows for comprehensive primary tumour (FFPE/gDNA) targeted resequencing with our Tumor Exome or Pan-Cancer (524 gene) TMB/MSI panel. Together our innovative products enable samples to be processed faster and with greater sensitivity and accuracy, while being compatible with leading instrumentation.
Video
Resources
Any questions? Contact:
Catherine Scerri
Business Development Manager UK & Ireland
catherine.scerri@nonacus.com
Chris Sale
CEO
chris.sale@nonacus.com
Live chat
If you see a 'Let's chat' icon on the bottom right of the page, it means that a representative is online and ready to chat and answer your questions! Click on the icon to chat with them.
If you see a 'Send message' button it means nobody is online right now, but you can send an email instead.
